We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-11.26%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$10.3B
AUM Growth
+$1.07B
Cap. Flow
+$2.36B
Cap. Flow %
22.99%
Top 10 Hldgs %
47.42%
Holding
1,109
New
276
Increased
252
Reduced
500
Closed
79

Top Buys

Rank Stock Value
1
WES icon
Western Midstream Partners
WES
+$619M
2
CCJ icon
Cameco
CCJ
+$146M
3
HESM icon
Hess Midstream
HESM
+$80.6M
4
VZ icon
Verizon
VZ
+$58.6M
5
MSFT icon
Microsoft
MSFT
+$51.2M

Sector Composition

Rank Sector Weight
1 Energy 60.43%
2 Technology 6.16%
3 Healthcare 4.82%
4 Consumer Discretionary 4.16%
5 Industrials 3.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRYS icon
476
Krystal Biotech
KRYS
$9.88B
$999K 0.01%
15,211
-10,702
-41% -$666K
MTCH icon
477
Match Group
MTCH
$8.84B
$999K 0.01%
+14,338
New +$1.16M
HLNE icon
478
Hamilton Lane
HLNE
$3.63B
$992K 0.01%
14,760
+10,070
+215% +$694K
AU icon
479
AngloGold Ashanti
AU
$40.3B
$989K 0.01%
66,844
+15,113
+29% +$287K
EBAY icon
480
eBay
EBAY
$48.6B
$989K 0.01%
+23,728
New +$1.16M
BAX icon
481
Baxter International
BAX
$11.6B
$974K 0.01%
+15,159
New +$1.1M
ALLO icon
482
Allogene Therapeutics
ALLO
$601M
$971K 0.01%
+85,190
New +$756K
EXPO icon
483
Exponent
EXPO
$2.98B
$970K 0.01%
+10,608
New +$999K
XNCR icon
484
Xencor
XNCR
$1.44B
$967K 0.01%
+35,320
New +$871K
NATI
485
DELISTED
National Instruments Corp
NATI
$967K 0.01%
30,955
+18,198
+143% +$645K
XENE icon
486
Xenon Pharmaceuticals
XENE
$6.32B
$958K 0.01%
+31,498
New +$953K
RTLR
487
DELISTED
Rattler Midstream LP Common Units
RTLR
$957K 0.01%
70,120
+7,305
+12% +$108K
IMCR icon
488
Immunocore
IMCR
$1.78B
$952K 0.01%
25,526
-18,700
-42% -$607K
MSCI icon
489
MSCI
MSCI
$40B
$948K 0.01%
+2,299
New +$1M
LFUS icon
490
Littelfuse
LFUS
$10.2B
$946K 0.01%
+3,722
New +$933K
FELE icon
491
Franklin Electric
FELE
$4.67B
$934K 0.01%
12,743
+8,523
+202% +$632K
WLY icon
492
John Wiley & Sons Class A
WLY
$2.52B
$931K 0.01%
+19,496
New +$996K
NWSA icon
493
News Corp Class A
NWSA
$14.5B
$926K 0.01%
+59,462
New +$1.09M
EBS icon
494
Emergent Biosolutions
EBS
$375M
$925K 0.01%
29,805
-22,100
-43% -$755K
EFC
495
Ellington Financial
EFC
$1.68B
$923K 0.01%
62,947
-519
-0.8% -$8.14K
TVTX icon
496
Travere Therapeutics
TVTX
$5.33B
$913K 0.01%
37,679
-27,576
-42% -$694K
VLTA
497
DELISTED
Volta Inc.
VLTA
$910K 0.01%
699,807
-31,800
-4% -$70.9K
LGND icon
498
Ligand Pharmaceuticals
LGND
$6.02B
$893K 0.01%
16,041
-11,729
-42% -$666K
STEP icon
499
StepStone Group
STEP
$3.48B
$885K 0.01%
34,000
-4,000
-11% -$109K
EA icon
500
Electronic Arts
EA
$52.4B
$878K 0.01%
+7,214
New +$920K

Similar funds

ALPS Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, ALPS Advisors held 1,109 positions worth $10.3B, up 12% from $9.22B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

ALPS Advisors deployed $2.36B of net new capital in Q2 2022, opening 276 new positions and adding to 252 existing holdings. Its largest new stake was Western Midstream Partners: 24,175,389 shares worth $588M.

By sector, the portfolio is most concentrated in Energy at 60% of assets, down from 66% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Energy Transfer Partners, an estimated $71M trimmed.

  • ALPS Advisors's largest Q2 2022 buy was Western Midstream Partners: 24,175,389 shares worth $588M.
  • ALPS Advisors added most to Hess Midstream in Q2 2022, an estimated $80.6M increase.
  • ALPS Advisors's biggest Q2 2022 reduction was Energy Transfer Partners, cutting an estimated $71M.
  • ALPS Advisors fully exited People's United Financial Inc in Q2 2022, selling an estimated $23.8M.
  • ALPS Advisors's ten largest holdings make up 47% of its $10.3B portfolio in Q2 2022.
  • ALPS Advisors opened 276 new positions and closed 79 in Q2 2022.
  • ALPS Advisors's portfolio value rose 12% quarter-over-quarter to $10.3B.

Based on ALPS Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.